OXFORD ASSET MANAGEMENT LLP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2019$1,777,000
+99.2%
348,014
-5.6%
0.05%
+133.3%
Q3 2019$892,000
-55.1%
368,757
-10.9%
0.02%
-59.6%
Q4 2018$1,987,000
+42.1%
413,953
+211.5%
0.05%
+79.3%
Q1 2018$1,398,000
-3.9%
132,882
-39.6%
0.03%
-6.5%
Q4 2017$1,455,000
+187.5%
220,145
+209.3%
0.03%
+210.0%
Q2 2017$506,000
-78.6%
71,166
-58.8%
0.01%
-82.1%
Q4 2015$2,359,000
+125.1%
172,693
+173.4%
0.06%
+100.0%
Q2 2013$1,048,00063,1600.03%
Other shareholders
IMMUNOGEN INC shareholders Q3 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders